Research Studies

Published research on HBOT for Peripheral Neuropathy

← Browse all conditions in the PubMed Research Library
These publications include different levels of evidence—not necessarily clinical trials. PubMed indexing is not proof of benefit or an endorsement. Summaries are based on available PubMed abstracts, not a formal full-text quality assessment. Read the limitations as well as the findings; some papers report no benefit or potential harms.

Plain English Summary

Patients with diabetic peripheral neuropathy receiving HBOT plus standard care had improved nerve conduction and vascular-flow measures compared with standard care alone.

Limitations & context: The abstract does not establish a blinded randomized design. Findings concern diabetic neuropathy, not every cause of peripheral nerve damage.

View on PubMed · PMID 38064614

Plain English Summary

Trials of adjunctive HBOT for diabetic peripheral neuropathy reported improvements in treatment-response and nerve-conduction measures.

Limitations & context: Publication bias was detected for some outcomes. The findings should not be generalized to other neuropathies without evidence.

View on PubMed · PMID 39252242

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting HBOT or any treatment. Individual results may vary.